Boehringer Ingelheim - Recruiting 18 years or older. - A Prospective, Open Label Study Evaluating the Efficacy of Two Management Strategies (Pantoprazole 40 mg q.a.m. and Taking PradaxaÂ® With Food (Within 30 Minutes After a Meal) on Gastrointestinal Symptoms (GIS) in Patients Newly on Treatment With PradaxaÂ® 150 mg b.i.d., 110 mg b.i.d. or 75 mg b.i.d. for the Prevention of Stroke and Systemic Embolism in Patients With Non-valvular Atrial Fibrillation (NVAF).
pantoprazole; Pradaxa (dabigatran etexilate); Pradaxa, within 30 minutes after a meal
Boehringer Ingelheim - Recruiting 18 years or older. - GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic TReatment In PAtients With Atrial Fibrillation (Phase II/III - EU/EEA Member States).
Bayer - Recruiting 18 years or older. - Belgian Real Life Non-interventional Study (NIS) on XareltoÂ® in Non-valvular Atrial Fibrillation (AF) Patients Treated for the Prevention of Stroke and Systemic Embolism (BOX-AF).
Medtronic International Trading Sarl - Recruiting 18 years to 75 years. - A Randomized, Controlled, Open-label, Parallel-group, Multi-center Study to Compare the Effect of Intrathecal Baclofen Therapy Versus Best Medical Treatment on Severe Spasticity in Post-stroke Patients After 6 Months Active Treatment.
University Hospital, Brest - Recruiting 18 years or older. - Is There a Link Between Venous Thromboembolism and Stroke in Patient With Patent Foramen Ovale ? Research for Stroke in Hospitalized Patients With Pulmonary Embolism..
AstraZeneca - Recruiting 50 years or older. - A Multinational, Randomised, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Ticagrelor 90 mg Twice Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Stroke in Patients With Type 2 Diabetes Mellitus (THEMIS - Effect of Ticagrelor on Health Outcomes in diabEtes Mellitus Patients Intervention Study).
Bayer - Recruiting 18 years or older. - XANTUS-EL, Xareltor on Prevention of Stroke and Noncentral Nervous System Systemic Embolism in Patients With Non-valvular Atrial Fibrillation in Eastern EU, Middle East, Africa (EMEA) and Latin America (LATAM): A Noninterventional Study.
AdvanceCor GmbH - Recruiting 18 years or older. - Revacept, an Inhibitor of Platelet Adhesion in Symptomatic Carotid Stenosis: A Phase II, Multicentre; Randomised, Dose-finding, Double-blind and Placebo Controlled Superiority Study With Parallel Groups.
Merz Pharmaceuticals GmbH - Recruiting 18 years to 80 years. - Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Study With an Open-label Extension Period to Investigate the Efficacy and Safety of NT 201 in the Treatment of Post-stroke Spasticity of the Lower Limb.
AstraZeneca - Recruiting 40 years or older. - A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA..
Jeil Pharmaceutical Co., Ltd. - Recruiting 19 years to 55 years. - A Phase I Clinical Study, Randomized, Double-blind, Placebo-controlled,Single Dose, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of JPI-289 in Healthy Male Subjects..
Bayer - Recruiting 18 years or older. - Xareltor on Prevention of Stroke and Non-central Nervous System Systemic Embolism in Patients With Non-valvular Atrial Fibrillation in Asia: A Non-interventional Study.
S. Andrea Hospital - Recruiting 18 years or older. - Phase II, Randomized, Crossover, Single Blind, Safety Trial of DABIGATRAN Versus ASA for Preventing Ischaemic Brain Lesions in Patients Affected by CADASIL.
BioControl Medical - Recruiting 18 years or older. - INcrease Of VAgal TonE in CHF (INOVATE-HF) - A Randomized Study to Establish the Safety and Efficacy of CardioFitr for the Treatment of Subjects With Heart Failure and Left Ventricular Dysfunction.
Mayo Clinic - Recruiting 18 years or older. - Endovascular Arterial Reperfusion vs. Intravenous ThromboLYsis for Acute Ischemic Stroke (EARLY): A Randomized Pilot Study of Ultra-early (<2 Hours) and Early (2-4.5 Hours) Reperfusion Therapy.
Penumbra Inc. - Recruiting 18 years to 85 years. - The THERAPY Trial: The Randomized, Concurrent Controlled Trial to Assess the Penumbra System's Safety and Effectiveness in the Treatment of Acute Stroke.
intravenous (IV) recombinant human tissue plasminogen activator (rtPA); Penumbra System
University of Sao Paulo General Hospital - Recruiting 18 years to 65 years. - Effects of Training in a Virtual Environment on the Motor Function, Cognition, Postural Control and Gait in Chronic Stroke Patients: A Randomized Controlled Trial.
China Academy of Chinese Medical Sciences - Recruiting 35 years to 80 years. - Efficacy and Safety of Qizhitongluo Capsule in the Recovery Phase of Ischemic Stroke With Qi Deficiency and Blood Stasis Syndrome: a Multicenter, Randomized,Double-blind,Placebo- and Active-controlled Adaptive Study.
North Shore Long Island Jewish Health System - Recruiting 18 years or older. - Effects of Transcranial Direct Current Stimulation Paired With Robotic Arm Therapy on Recovery of Upper Extremity Motor Function in Stroke Patients.
Transcranial Direct Current Stimulation (tDCS); Placebo sham
Bayer - Recruiting 18 years or older. - Prospective Multicenter Observational Non-interventional Local Study on Prescription Behavior of Anticoagulation Therapy in Secondary Stroke Prevention in Atrial Fibrillation Patients.
National Rehabilitation Center, Seoul, Korea - Recruiting 18 years or older. - Effects of Novel Game Rehabilitation System (E-glove System) on Upper Extremity Function of Patients With Stroke :Randomized Controlled Trial.
AtriCure, Inc. - Recruiting 18 years to 80 years. - Feasibility Clinical Investigation of a Minimally Invasive Surgically Deployed AtriCure AtriClip Left Atrial Appendage Exclusion System for Stroke Prophylaxis in Patients With Non-Valvular Atrial Fibrillation and in Whom Long Term Oral Anticoagulation Therapy is Medically Contraindicated.
Hopital Foch - Recruiting 18 years or older. - Accuracy of Pulse Pressure Variation (Nexfin) and of Pleth Variability Index (Radical 7) to Predict the Response to a Fluid Challenge: Comparison With the Reference Method (Measurement of Stroke Volume by Esophageal Doppler).
University Hospital of Ferrara - Recruiting 18 years to 75 years. - Efficacy of a Task-oriented Circuit Training Associated With Transcranial Direct Current Stimulation (tDCS) for Gait Improvement in Chronic Stroke Patients . A Randomized Controlled Trial.
Lawson Health Research Institute - Recruiting 18 years or older. - A Double Blind Randomized Control Trial of Post-Operative Low Molecular Weight Heparin Bridging Therapy Versus Placebo Bridging Therapy for Patients Who Are at High Risk for Arterial Thromboembolism (PERIOP 2).
Seoul National University Hospital - Recruiting 20 years to 60 years. - Vasodilator-induced Hypovolemia in Living Liver Donors: Central Venous Pressure-guided vs Stroke Volume Variation-guided Technique.
Azienda Ospedaliero-Universitaria Careggi - Recruiting 18 years or older. - The Rehabilitation of Attention in Patients With Mild Cognitive Impairment and Brain Subcortical Vascular Changes Using the Attention Process Training-II.
Janssen Research & Development, LLC - Recruiting 18 years to 95 years. - A Randomized, Double-blind, Event-driven, Multicenter Study Comparing the Efficacy and Safety of Oral Rivaroxaban With Placebo for Reducing the Risk of Death, Myocardial Infarction or Stroke in Subjects With Chronic Heart Failure and Significant Coronary Artery Disease Following a Hospitalization for Exacerbation of Heart Failure.
Rivaroxaban; Placebo; Standard of care for heart failure and coronary artery disease
China Academy of Chinese Medical Sciences - Recruiting 18 years to 70 years. - A Randomized, Multi-center, Double-blind, Placebo-controlled Trial of Danhong Injection in the Treatment of Acute Ischemic Stroke.
University Hospital, Toulouse - Recruiting 18 years to 80 years. - Comparaison de l'efficacit du Renforcement Des Muscles flchisseurs et Extenseurs du Genou et de la kinsithrapie Conventionnelle Chez l'hmiplgique en Phase Chronique : tude Prospective, Pragmatique, en Intention de Traiter, randomise, en Simple Insu, Multicentrique..
Muscular Strengthening for paretic knee flexor and extensor; conventional physiotherapy
University of Rostock - Recruiting 18 years to 55 years. - Stroke in Young Fabry Patients (sifap2): Characterization of the Stroke Rehabilitation in Young Patients With Fabry Disease: An Epidemiological, International, Multicenter Prognosis Study.
Samsung Medical Center - Recruiting N/A or older. - Safety and Efficacy of Therapeutic Induced Hypertension in Patients With Acute Non-cardioembolic Ischemic Stroke: A Multicenter, Randomized, Open Label, Prospective, Phase 3 Study.
Xuanwu Hospital, Beijing - Recruiting 30 years to 80 years. - China Angioplasty & Stenting for Symptomatic Intracranial Severe Stenosis (CASSISS): A Prospective Multi-center, Randomized Controlled Trial (RCT).
University Hospital of Mont-Godinne - Recruiting 18 years to 85 years. - Therapeutic Impact of tDCS on Dysphagia in the Acute Phase of Stroke / Impact thrapeutique de la tDCS Sur la Dysphagie en Phase Aigue de l'Accident Vasculaire crbral.
Diakron Pharmaceuticals - Recruiting 18 years to 50 years. - A Randomized, Double-blind, Placebo-controlled, Stepwise Study of the Pharmacokinetics (PK), Pharmacodynamics (PD), PK/PD Characteristics and Safety of Multiple Once-daily Oral Dosing of DPOC-4088 in Healthy Young Male Subjects.
Asan Medical Center - Recruiting 40 years or older. - Multicenter Clinical Trial for Development of Guidelines of Adequate Blood Pressure Lowering in the Subacute Ischemic Stroke Patients Due to Intracranial Atherosclerosis.
Aggressive BP lowering; modest blood pressure lowering
Hallym University Medical Center - Recruiting 18 years or older. - Prospective, Randomized, Open-label, Blinded Endpoints, Multi-center Study to Evaluate the Efficacy of Modest Blood Pressure Reduction With Diovanr (Valsartan) in Acute Ischemic Stroke.
National Taiwan University Hospital - Recruiting 45 years to 75 years. - Modified Constraint-Induced Movement Therapy and Eye Patching for Neglect Rehabilitation Post Stroke: A Longitudinal Study of Separate and Combined Effects.